Alexander Veronica J.,Viney Nicholas J.,Witztum Joseph L.
申请号：
NZ63111914
公开号：
NZ631119A
申请日:
2014.02.14
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
Disclosed is the use of an ApoCIII specific inhibitor in the manufacture of a medicament for treating, preventing, delaying or ameliorating Familial Chylomicronemia Syndrome (FCS) or Lipoprotein Lipase Deficiency (LPLD) in an animal. Further disclosed is the use of an ApoCIII specific inhibitor in the manufacture of a medicament for preventing, delaying or ameliorating pancreatitis, or symptom thereof, in an animal with FCS or LPLD.
